行情

BIOC

BIOC

Biocept
NASDAQ

实时行情|Nasdaq Last Sale

0.7025
-0.0315
-4.29%
交易中 09:43 07/16 EDT
开盘
0.7037
昨收
0.7340
最高
0.7050
最低
0.6840
成交量
342.33万
成交额
--
52周最高
1.150
52周最低
0.2112
市值
9,209.84万
市盈率(TTM)
-0.7545
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测BIOC价格均价为1.530,最高价位2.060,最低价为1.000。

EPS

BIOC 新闻

更多
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Both Support Biocept Proposal to Authorize the Reverse Split of Common Shares
PR Newswire · 38分钟前
Leading Independent Proxy Advisory Firms ISS And Glass Lewis Both Support Biocept Proposal To Authorize Reverse Split Of Common Shares
SAN DIEGO, July 16, 2020 /PRNewswire/ -- Biocept, Inc. (NASDAQ:BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the
Benzinga · 1小时前
Benzinga Pro's Top 3 Stocks To Watch For Wed., Jul. 8, 2020: BBBY, VBIV, BIOC
Today's 3 Stock Ideas:  Bed Bath & Beyond (BBBY) - An earnings play. Will report quarterly results on Thursday before market open. VBI Vaccines (VBIV) - Shares closed up 20% on Tuesday and were
Benzinga · 07/08 12:37
Biocept nabs Canadian patent covering enhanced cell detection methods
Seeking Alpha - Article · 06/30 14:12
Biocept Awarded Canadian Patent Covering the Enhanced Detection of Rare Cells, including Cancer Cells, from a Biological Fluid Sample such as Blood or Cerebrospinal Fluid
PR Newswire · 06/30 13:05
Biocept Awarded Canadian Patent Covering Enhanced Detection Of Rare Cells, Including Cancer Cells, From Biological Fluid Sample Such As Blood Or Cerebrospinal Fluid
Benzinga · 06/30 12:12
Biocepts Covid-19 Testing Capacity Puts It at the Head of the Pack
TipRanks · 06/27 03:04
Biocept Enters Into Agreement with Reference-based Pricing Network Medical Cost Containment Professionals, LLC to Process Out-of-Network Claims
PR Newswire · 06/24 13:05

所属板块

医疗设备、用品及经销
-1.02%
医疗设备和用品
-0.87%

热门股票

代码
价格
涨跌幅

BIOC 简况

Biocept Inc是一家分子肿瘤诊断公司。该公司开发和商业化循环肿瘤细胞(CTC)和循环肿瘤脱氧核糖核酸(ctDNA),并利用标准血液样品或液体活检。该公司的产品Target-Selector基于内部开发的微流体CTC捕获与分析平台,通过提供仅需标准血液样品的生物标志物检测与监测来改变临床医生使用CTC检测的方法。ctDNA技术能够进行突变检测,并适用于来自CTC或其他样品类型(如血浆)的核酸。该公司商业化Target-Selector,以治疗一系列实体肿瘤适应症,如乳腺癌、非小细胞肺癌(NSCLC)、小细胞肺癌(SCLC)、胃癌、结肠直肠癌、前列腺癌和黑素瘤。
展开

微牛提供Biocept Inc(NASDAQ-BIOC)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的BIOC股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易BIOC股票基本功能。